Androgenetic Alopecia May Be Associated With Weaker COVID-19 T-Cell Immune Response: An Insight Into a Potential COVID-19 Vaccine Booster

January 2021 in “ Medical Hypotheses ”

Andy Goren, Flavio A. Cadegiani, Carlos Gustavo Wambier, Sergio Vano-Galvan, Antonella Tosti, Jerry Shapiro, Natasha Atanaskova Mesinkovska, Paulo Müller Ramos, Rodney Sinclair, Omar Lupi, Jana Hercogová, John D. McCoy

androgenetic alopecia T-cell immune response COVID-19 vaccine androgen receptor androgens AGA COVID-19

TLDR Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

There is a potential association between androgenetic alopecia (AGA) and a weaker T-cell immune response to COVID-19, which could impact the effectiveness of COVID-19 vaccines. The authors propose that a booster vaccine targeting the androgen receptor may be necessary for individuals with AGA to achieve adequate protection against the virus. Further studies are needed to determine the role of androgens and the androgen receptor in modulating the immune response to COVID-19.

View this study on sciencedirect.com →

Androgenetic Alopecia May Be Associated With Weaker COVID-19 T-Cell Immune Response: An Insight Into a Potential COVID-19 Vaccine Booster

Cited in this study

research Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign'

research What Does Androgenetic Alopecia Have to Do with COVID-19? An Insight into a Potential New Therapy